Privia Health Group, Inc. (NASDAQ:PRVA) Receives Consensus Recommendation of “Buy” from Brokerages

Privia Health Group, Inc. (NASDAQ:PRVA) has received an average rating of “Buy” from the sixteen brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, thirteen have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $26.67.

A number of equities research analysts have weighed in on the stock. Macquarie began coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 target price for the company. Stephens restated an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a research note on Thursday, January 2nd. Canaccord Genuity Group upped their price objective on Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. Needham & Company LLC reiterated a “buy” rating and issued a $30.00 price target on shares of Privia Health Group in a research note on Friday. Finally, JPMorgan Chase & Co. increased their price target on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th.

Privia Health Group Trading Up 0.2 %

PRVA stock opened at $23.34 on Monday. The stock has a market capitalization of $2.81 billion, a PE ratio of 233.42, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $26.04. The stock’s 50 day simple moving average is $23.65 and its 200 day simple moving average is $21.05.

Hedge Funds Weigh In On Privia Health Group

Large investors have recently bought and sold shares of the business. Nordea Investment Management AB raised its stake in Privia Health Group by 33.1% in the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock worth $6,953,000 after buying an additional 86,910 shares in the last quarter. Victory Capital Management Inc. raised its stake in Privia Health Group by 402.9% in the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock worth $3,260,000 after buying an additional 143,446 shares in the last quarter. Rhumbline Advisers raised its stake in Privia Health Group by 1.3% in the fourth quarter. Rhumbline Advisers now owns 287,200 shares of the company’s stock worth $5,615,000 after buying an additional 3,658 shares in the last quarter. Franklin Resources Inc. raised its stake in Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after buying an additional 28,480 shares in the last quarter. Finally, Barclays PLC raised its stake in Privia Health Group by 240.3% in the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after buying an additional 158,188 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.